Latest aplastic anemia Stories
RnRMarketResearch.com adds "Aplastic Anemia Global Clinical Trials Review, H2, 2014" to its store.
To mark National Sickle Cell Month which occurs every September, the Editorial Board of Living with a Disability magazine has published an important new article that sheds light on hematological
- New first-in-class treatment option for this previously treated SAA patient population LONDON, Aug.
Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all standard therapies.
A new discovery in mice may lead to new treatments that could make bone marrow transplants more likely to succeed and to be significantly less dangerous.
Being anemic could more than triple your risk of dying within a year after having a stroke.
Hematopoietic cell transplantation (HCT), the transplantation of blood-forming stem cells from the bone marrow, peripheral blood, or umbilical cord blood, is the primary option for treatment for many patients who suffer from various hematologic disorders, including blood cancers, sickle cell disease, bone marrow deficiencies, bleeding disorders, and autoimmune disorders.
- The parings of haberdine; also, any kind of fragments.